Workflow
伟思医疗: 南京伟思医疗科技股份有限公司关于公司2025年限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告

Core Viewpoint - The company conducted a self-examination regarding insider trading related to its 2025 restricted stock incentive plan, confirming that no insider trading occurred during the review period [1][2][3] Group 1: Self-Examination Process - The self-examination covered the period from October 25, 2024, to April 25, 2025, focusing on stock trading activities of insider information recipients [1] - The company implemented necessary confidentiality measures and registered insider information recipients as per relevant regulations [2] Group 2: Findings on Insider Trading - During the self-examination period, three insider information recipients engaged in stock trading, while others did not participate in any trading activities [2] - The trading actions of the three individuals were based on publicly disclosed information and their independent judgment, with no prior knowledge of the incentive plan [2][3] - The company found no evidence of insider trading or information leakage related to the incentive plan, confirming compliance with relevant regulations [3]